Temasek considers $1 bln sale of Zuellig Pharma stake: Bloomberg

Temasek Holdings Pte is in talks with advisers about a potential sale of its stake in Asian drug distributor Zuellig Pharma, Bloomberg reported. Temasek may seek $1 billion for its roughly 20 percent stake of Zuellig, the story said. The auction is expected to draw interest from private equity firms and strategics, including Mitsui & Co, Bloomberg said.